Marc Pellet

Title: Marc Pellet: Innovator in Pharmaceutical Compositions

Introduction

Marc Pellet is a notable inventor based in Conde sur Iton, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on innovative compositions that aim to improve therapeutic outcomes.

Latest Patents

One of Marc Pellet's latest patents involves pharmaceutical compositions comprising 2-isoxazoles-8-aminotetralin derivatives. This invention relates to novel compositions in the form of a patch that contains a therapeutically efficacious amount of a specific derivative. The derivative, particularly 1,2,3,4-tetrahydro-8-(5-isoxazolyl)-N,N-diisopropyl-2-naphtalenamine, is designed to treat irritable bowel syndrome through transdermal administration. Another significant patent focuses on pharmaceutical compositions for prolonged peptide release. This solid or semisolid composition includes a gellable and water-soluble peptide salt, which forms a gel upon injection, allowing for the sustained release of the peptide over a period of at least 15 days.

Career Highlights

Throughout his career, Marc Pellet has worked with various organizations, including Societe de Conseils de Recherches et d'Applications Scientifiques (SCRAS) and Pharma Biotech. His experience in these companies has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Marc has collaborated with several professionals in his field, including Chantal Roume and Frederic Bismuth. These collaborations have likely enhanced his research and development efforts.

Conclusion

Marc Pellet is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact medical treatments. His innovative approaches and collaborations reflect his commitment to advancing healthcare solutions.